New drugs should be compared with existing treatments before approval, say experts

Manufacturers should have to show how their drugs compare to existing treatments before approval to help ensure that the most beneficial and safest therapies reach patients and that limited healthcare resources are invested wisely, argue experts in BMJ today.

Read the whole article on Physorg

More from Physorg